Your Trusted Generics Medicine Supplier
Mumbai, India
Your safety is our priority. Report any adverse events related to Mefloquine tablets.
An adverse event is any undesirable medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.
At Taj Pharma, we are committed to monitoring the safety of our Mefloquine Hydrochloride Tablets USP 250mg and encourage healthcare professionals and patients to report any suspected adverse events.
Use this form to report adverse events directly to Taj Pharma's pharmacovigilance department.
Adverse events can be reported 24/7 through our helpline numbers.
All reports are treated with strict confidentiality and processed according to regulatory requirements.
For serious or unexpected adverse events, please report immediately.
Reports are shared with global pharmacovigilance databases for worldwide safety monitoring.